Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT
Conditions: Allogeneic Hematopoietic Stem Cell Transplantation; Acute Myeloid Leukemia; Myelodysplastic Syndrome Intervention: Drug: VEN+AZA+Modified BUCY Sponsor: The First Affiliated Hospital of Soochow University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Myeloid Leukemia | Hospitals | Leukemia | Myelodysplastic Syndrome | Research | Stem Cell Therapy | Stem Cells | Transplants